Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Othman

Showing results (141-150 of 476) with videos related to

Pageof 48
Sort By:
Molecular Biology Reports|October 16, 2012
Sequence analysis and gene expression of putative oil palm chitinase and chitinase-like proteins in response to colonization of Ganoderma boninense and Trichoderma harzianumK-A Yeoh, A Othman, S Meon, et al.
Metabolic Brain Disease|July 1, 2026
The protective role of melatonin on the brain in a rat model of Alzheimer's diseaseSarah S Mostafa, Rabab A Mohammed, Asmaa Y Abbas, et al.
Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology|September 3, 2025
Prevalence of intestinal parasitic infections for six years (2015-2020) in Thi-Qar Province, IraqMohammed H Flaih, Rana A Othman, Ali T Hameed, et al.
Journal of Clinical Pharmacology|August 27, 2019
Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure-Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to TofacitinibMohamed-Eslam F Mohamed, Denise Beck, Heidi S Camp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuseAhmed A Othman, Shariq A Syed, Amy H Newman, et al.
Clinical Pharmacology : Advances and Applications|March 2, 2016
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosisJonathan Q Tran, Ahmed A Othman, Alvydas Mikulskis, et al.
Food & Function|February 26, 2026
Starch modification differentially affects the <i>in vivo</i> protein quality of cereal-based dietsMousa Numan Ahmad, Ayed S Amr, Ghadeer A Othman, et al.
Cureus|November 1, 2023
Is Online Patient-Centered Information About Implant Bone Graft Valid?Muath S Alassaf, Hassan A Hammudah, Esam S Almuzaini, et al.
Journal of the Egyptian Society of Parasitology|January 28, 2011
A preliminary study on the prevalence of parasitic infections in immunocompromised childrenSanaa N Antonios, Osama A Tolba, Ahmad A Othman, et al.
Journal of Clinical Pharmacology|November 6, 2020
Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 DosesMohamed-Eslam F Mohamed, Sathej Gopalakrishnan, Henrique D Teixeira, et al.
Pageof 48

Showing results (141-150 of 476) with videos related to

Sort By:
Pageof 48
Molecular Biology Reports|October 16, 2012
Sequence analysis and gene expression of putative oil palm chitinase and chitinase-like proteins in response to colonization of Ganoderma boninense and Trichoderma harzianumK-A Yeoh, A Othman, S Meon, et al.
Metabolic Brain Disease|July 1, 2026
The protective role of melatonin on the brain in a rat model of Alzheimer's diseaseSarah S Mostafa, Rabab A Mohammed, Asmaa Y Abbas, et al.
Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology|September 3, 2025
Prevalence of intestinal parasitic infections for six years (2015-2020) in Thi-Qar Province, IraqMohammed H Flaih, Rana A Othman, Ali T Hameed, et al.
Journal of Clinical Pharmacology|August 27, 2019
Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure-Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to TofacitinibMohamed-Eslam F Mohamed, Denise Beck, Heidi S Camp, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
Transport, metabolism, and in vivo population pharmacokinetics of the chloro benztropine analogs, a class of compounds extensively evaluated in animal models of drug abuseAhmed A Othman, Shariq A Syed, Amy H Newman, et al.
Clinical Pharmacology : Advances and Applications|March 2, 2016
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosisJonathan Q Tran, Ahmed A Othman, Alvydas Mikulskis, et al.
Food & Function|February 26, 2026
Starch modification differentially affects the <i>in vivo</i> protein quality of cereal-based dietsMousa Numan Ahmad, Ayed S Amr, Ghadeer A Othman, et al.
Cureus|November 1, 2023
Is Online Patient-Centered Information About Implant Bone Graft Valid?Muath S Alassaf, Hassan A Hammudah, Esam S Almuzaini, et al.
Journal of the Egyptian Society of Parasitology|January 28, 2011
A preliminary study on the prevalence of parasitic infections in immunocompromised childrenSanaa N Antonios, Osama A Tolba, Ahmad A Othman, et al.
Journal of Clinical Pharmacology|November 6, 2020
Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 DosesMohamed-Eslam F Mohamed, Sathej Gopalakrishnan, Henrique D Teixeira, et al.
Pageof 48